You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Phase II: Hardness Strength and Ductility Tester for Field Assessment of Structures
SBC: MASSACHUSETTS MATERIALS TECHNOLOGIES LLC Topic: MIThis Small Business Innovation Research (SBIR) Phase II project will support the technological refinement and concomitant commercialization of the first accurate and portable instrument that can perform in the field nondestructive test for hardness, strength and ductility of existing infrastructure. The material properties measured include yield strength, work hardening exponent and ultimate tensi ...
SBIR Phase II 2017 National Science Foundation -
SBIR Phase II: An embedded and in-context professional learning platform for math problem-solving instruction
SBC: Cuethink, Inc. Topic: EAThis project proposes to develop an innovative approach to improve and sustain math educators' problem solving teaching skills. Despite the expectations placed on math teachers by the Common Core State Standards, most are insufficiently prepared to teach students how to become critical thinkers. Much of this problem is due to limited pedagogical skills of teachers in providing adequate problem sol ...
SBIR Phase II 2017 National Science Foundation -
SBIR Phase II: Anti-fouling surface modifications for purification membranes
SBC: DropWise Technologies Corp. Topic: MIThis Small Business Innovation Research (SBIR) Phase II project will address the challenge of fouling on membranes used in biopharmaceutical processing. The successful application of this coating would enable increase in the membrane lifetime and product yield of various production streams as less of the valuable compounds remain trapped in the membrane. This can increase production capacity for l ...
SBIR Phase II 2017 National Science Foundation -
Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls
SBC: BOSTON CELL STANDARDS INC. Topic: 102The broadlongterm goal of this project is consistentstandardized diagnostic testing of surgicalspecimens by immunohistochemistryIHCThe methods to achieve this goal are well understood in thefield of clinical laboratory testingstandardization of reagents and protocolsautomation toreduce human errorsandthe use of standardized controls to provide test performance feedbackOver the last two decadesthe ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
SBC: Curadel, LLC Topic: 102PROJECT SUMMARY ABSTRACTImage guided surgery using invisible near infraredNIRlight is in the midst of a renaissanceMultiple commercial imaging systemsincluding Curadel s state of the art FLAREsystemare available for preclinicalveterinaryand human surgeryHoweverthe ultimate success of the field will depend on innovative NIR fluorophores that solve important clinical problemsCuradel has invented a n ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Gyrase Inhibitor for the Treatment of Drug-susceptible and Multidrug-resistant Mycobacterium tuberculosis Infections
SBC: Spero Therapeutics, Inc. Topic: NIAIDABSTRACT TuberculosisTBcaused by the bacterial pathogen Mycobacterium tuberculosisMtbremains a leading cause of death in the world today despite the availability of therapeutic drugs for more than sixty yearsThe disease also exacts a significant economic toll in countries where it is prevalentoften in poorer areas of the worldMultidrug resistant TBMDR TB and XDR TBis an increasing problemwith near ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Dual Mode Hand Held Intraoperative Imager
SBC: RADIATION MONITORING DEVICES, INC. Topic: 102Radionuclide guided intraoperative probes increase the specificity of tissue biopsiesenable minimalaccess incisionsreduce inpatient hospital utilizationand contribute to improved patient recoveryAt presentmost such probes on the market are non imagingand provide no ancillary information of surveyed areassuch as clear delineations of malignant tissuesOur goal is to develop a revolutionary new imagi ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Monitoring Pesticide Exposure and Accumulation: An Improved Rapid Identifier for all Pesticide Classes
SBC: EIC LABORATORIES, INC. Topic: NIEHSProject Summary The proposed program aims to quantify farmworker exposure to pesticides using Surface Enhanced Raman SpectroscopySERSand an inexpensive sensor which can also be used for urinalysisAn earlier programsupported by NIEHSprovided reliable results for organophosphateOPand organochlorineOCpesticidesFifty OP and OC pesticides and metabolites were evaluated in the laboratory in the low ppb ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes
SBC: AKSTON BIOSCIENCES CORPORATION Topic: 200PUBLIC DESCRIPTION Akston is developing a subcutaneously administered therapeutic for preventing or delaying the onset of diabetes in pre diabetic patients who are at high riskthose who display autoantibodies for insulinGADIAand ZnTfor developing TypediabetesT DThe therapeutic is designed to delete a subset of B cells that likely play a role in disease development using a patient s own antibody di ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing
SBC: Mattek Corporation Topic: NIEHSResults of Phase II research indicate that formal validation of the EpiAirwayin vitro human bronchial tissue model for predicting toxicity of inhaled chemicals is an attainable goalThe proposed Phase IIB cooperative agreement project is intended to realize this goal by conducting formal ring trial validation studies that will be submitted to regulatory agencies and the Organization for Economic Co ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health